{"id":17474,"date":"2016-06-30T00:00:00","date_gmt":"2016-06-30T00:00:00","guid":{"rendered":"https:\/\/cadca1stg.wpengine.com\/resource\/dea-releases-2016-national-heroin-threat-assessment-summary\/"},"modified":"2016-06-30T00:00:00","modified_gmt":"2016-06-30T00:00:00","slug":"dea-releases-2016-national-heroin-threat-assessment-summary","status":"publish","type":"resource","link":"https:\/\/www.cadca.org\/fr\/resource\/dea-releases-2016-national-heroin-threat-assessment-summary\/","title":{"rendered":"La DEA publie le r\u00e9sum\u00e9 de l&#039;\u00e9valuation nationale de la menace li\u00e9e \u00e0 l&#039;h\u00e9ro\u00efne 2016"},"content":{"rendered":"<p>La Drug Enforcement Administration (DEA) a publi\u00e9 le <a href=\"https:\/\/www.dea.gov\" target=\"_blank\" rel=\"noopener\">R\u00e9sum\u00e9 de l&#039;\u00e9valuation nationale de la menace li\u00e9e \u00e0 l&#039;h\u00e9ro\u00efne de 2016<\/a> cette semaine.<\/p>\n<p>Certains faits cl\u00e9s sont :<\/p>\n<ul>\n<li>Le nombre de personnes d\u00e9clarant consommer actuellement de l&#039;h\u00e9ro\u00efne a presque tripl\u00e9 entre 2007 (161\u00a0000) et 2014 (435\u00a0000).\u00a0<\/li>\n<li>Les d\u00e9c\u00e8s dus aux opio\u00efdes synth\u00e9tiques, tels que le fentanyl et ses analogues, ont augment\u00e9 de 79 % entre 2013 et 2014.<\/li>\n<li>Les d\u00e9c\u00e8s li\u00e9s \u00e0 l&#039;h\u00e9ro\u00efne ont plus que tripl\u00e9 entre 2010 (3 036) et 2014 (10 574) \u2013 un taux plus rapide que celui des autres drogues illicites.<\/li>\n<\/ul>\n<p>La nouveaut\u00e9 du r\u00e9sum\u00e9 de cette ann\u00e9e est l&#039;information sur un ph\u00e9nom\u00e8ne r\u00e9cent - le fentanyl d\u00e9guis\u00e9 en pilules sur ordonnance - quelque chose qui serait responsable de la mort de 19 personnes en Floride et en Californie au cours du premier trimestre de 2016. Motiv\u00e9s par un \u00e9norme potentiel de profit, les trafiquants exploitent la forte demande des consommateurs pour les analg\u00e9siques, les tranquillisants et les s\u00e9datifs illicites sur ordonnance en produisant des contrefa\u00e7ons peu co\u00fbteuses contenant du fentanyl qui peuvent \u00eatre vendues dans la rue.<\/p>\n<p>&quot;Nous avons tendance \u00e0 abuser de mots tels que&quot; sans pr\u00e9c\u00e9dent &quot;et&quot; horrible &quot;, mais la mort et la destruction li\u00e9es \u00e0 l&#039;h\u00e9ro\u00efne et aux opio\u00efdes sont, en effet, sans pr\u00e9c\u00e9dent et horribles&quot;, a d\u00e9clar\u00e9 l&#039;administrateur par int\u00e9rim de la DEA, Chuck Rosenberg, dans un communiqu\u00e9 de presse. &quot;Le probl\u00e8me est \u00e9norme et croissant, et tous nos citoyens doivent prendre conscience de ces faits.&quot;<\/p>\n<p>Le nombre d&#039;usagers, d&#039;admissions en traitement, de d\u00e9c\u00e8s par surdose et de saisies par des trafiquants a tous augment\u00e9 par rapport \u00e0 ceux signal\u00e9s dans le r\u00e9sum\u00e9 de l&#039;ann\u00e9e derni\u00e8re. En outre, l&#039;h\u00e9ro\u00efne \u00e9tait la plus grande menace li\u00e9e \u00e0 la drogue signal\u00e9e par 45\u00a0% (contre 38\u00a0% l&#039;an dernier et 7\u00a0%, en comparaison, en 2007) des organismes d&#039;application de la loi des \u00c9tats, locaux et tribaux ayant r\u00e9pondu \u00e0 l&#039;enqu\u00eate nationale de 2016 sur la menace li\u00e9e \u00e0 la drogue.<\/p>\n<p><strong>VOIR \u00c9GALEMENT:<\/strong><\/p>\n<p><a href=\"https:\/\/www.cadca.org\/fr\/news\/cadca-joins-deas-comprehensive-strategy-address-heroin-opioid-abuse-and-violent-crime\/\" target=\"_blank\" rel=\"noopener\">La CADCA rejoint la strat\u00e9gie globale de la DEA pour lutter contre l&#039;abus d&#039;h\u00e9ro\u00efne, d&#039;opio\u00efdes et les crimes violents<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>The Drug Enforcement Administration (DEA) released the 2016\u00a0National Heroin Threat Assessment Summary this week. Some key facts are: The number<\/p>","protected":false},"author":23,"featured_media":0,"template":"","resource_type":[281],"drug_specific_issues":[312],"action_to_do":[],"class_list":["post-17474","resource","type-resource","status-publish","hentry","resource_type-coalitions-online","drug_specific_issues-heroin"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>DEA Releases 2016 National Heroin Threat Assessment Summary | CADCA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cadca.org\/fr\/resource\/dea-releases-2016-national-heroin-threat-assessment-summary\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"DEA Releases 2016 National Heroin Threat Assessment Summary | CADCA\" \/>\n<meta property=\"og:description\" content=\"The Drug Enforcement Administration (DEA) released the 2016\u00a0National Heroin Threat Assessment Summary this week. Some key facts are: The number\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cadca.org\/fr\/resource\/dea-releases-2016-national-heroin-threat-assessment-summary\/\" \/>\n<meta property=\"og:site_name\" content=\"CADCA\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cadca.org\/wp-content\/uploads\/2022\/03\/cadca-member-of-logo1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"880\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/resource\\\/dea-releases-2016-national-heroin-threat-assessment-summary\\\/\",\"url\":\"https:\\\/\\\/www.cadca.org\\\/resource\\\/dea-releases-2016-national-heroin-threat-assessment-summary\\\/\",\"name\":\"DEA Releases 2016 National Heroin Threat Assessment Summary | CADCA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/#website\"},\"datePublished\":\"2016-06-30T00:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/resource\\\/dea-releases-2016-national-heroin-threat-assessment-summary\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cadca.org\\\/resource\\\/dea-releases-2016-national-heroin-threat-assessment-summary\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/resource\\\/dea-releases-2016-national-heroin-threat-assessment-summary\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cadca.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"DEA Releases 2016 National Heroin Threat Assessment Summary\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/#website\",\"url\":\"https:\\\/\\\/www.cadca.org\\\/\",\"name\":\"CADCA\",\"description\":\"The Premier Prevention Association\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cadca.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"DEA Releases 2016 National Heroin Threat Assessment Summary | CADCA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cadca.org\/fr\/resource\/dea-releases-2016-national-heroin-threat-assessment-summary\/","og_locale":"fr_FR","og_type":"article","og_title":"DEA Releases 2016 National Heroin Threat Assessment Summary | CADCA","og_description":"The Drug Enforcement Administration (DEA) released the 2016\u00a0National Heroin Threat Assessment Summary this week. Some key facts are: The number","og_url":"https:\/\/www.cadca.org\/fr\/resource\/dea-releases-2016-national-heroin-threat-assessment-summary\/","og_site_name":"CADCA","og_image":[{"width":880,"height":500,"url":"https:\/\/www.cadca.org\/wp-content\/uploads\/2022\/03\/cadca-member-of-logo1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cadca.org\/resource\/dea-releases-2016-national-heroin-threat-assessment-summary\/","url":"https:\/\/www.cadca.org\/resource\/dea-releases-2016-national-heroin-threat-assessment-summary\/","name":"DEA Releases 2016 National Heroin Threat Assessment Summary | CADCA","isPartOf":{"@id":"https:\/\/www.cadca.org\/#website"},"datePublished":"2016-06-30T00:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.cadca.org\/resource\/dea-releases-2016-national-heroin-threat-assessment-summary\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cadca.org\/resource\/dea-releases-2016-national-heroin-threat-assessment-summary\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.cadca.org\/resource\/dea-releases-2016-national-heroin-threat-assessment-summary\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cadca.org\/"},{"@type":"ListItem","position":2,"name":"DEA Releases 2016 National Heroin Threat Assessment Summary"}]},{"@type":"WebSite","@id":"https:\/\/www.cadca.org\/#website","url":"https:\/\/www.cadca.org\/","name":"CADCA","description":"The Premier Prevention Association","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cadca.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/resource\/17474","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/resource"}],"about":[{"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/types\/resource"}],"author":[{"embeddable":true,"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/users\/23"}],"version-history":[{"count":0,"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/resource\/17474\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/media?parent=17474"}],"wp:term":[{"taxonomy":"resource_type","embeddable":true,"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/resource_type?post=17474"},{"taxonomy":"drug_specific_issues","embeddable":true,"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/drug_specific_issues?post=17474"},{"taxonomy":"action_to_do","embeddable":true,"href":"https:\/\/www.cadca.org\/fr\/wp-json\/wp\/v2\/action_to_do?post=17474"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}